IgG4-RD: From Diagnostic Delays to Collective Action in Rare Disease Care

Amgen examines IgG4-related disease (IgG4-RD), a rare immune-mediated condition often marked by lengthy diagnostic delays, and highlights the need for collective action across the rare disease care community to improve recognition and treatment.